Basal cell carcinoma future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Basal cell carcinoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Epithelial neoplasms}} {{Diseases of the skin and appendages by morphology}} {{Tumors of bone, c..." |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 9: | Line 9: | ||
{{Diseases of the skin and appendages by morphology}} | {{Diseases of the skin and appendages by morphology}} | ||
{{Tumors of bone, cartilage, skin, connective, and soft tissue}} | {{Tumors of bone, cartilage, skin, connective, and soft tissue}} | ||
<br> | <br> | ||
[[de:Basaliom]] | [[de:Basaliom]] | ||
Revision as of 22:46, 8 August 2012
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma future or investigational therapies |
|
FDA on Basal cell carcinoma future or investigational therapies |
|
CDC on Basal cell carcinoma future or investigational therapies |
|
Basal cell carcinoma future or investigational therapies in the news |
|
Blogs on Basal cell carcinoma future or investigational therapies |
|
Risk calculators and risk factors for Basal cell carcinoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
References
Template:Tumors of bone, cartilage, skin, connective, and soft tissue